Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment-Reference-Cited by-同舟云学术

Factors associated with treatment retention in pregnant women with opioid use disorders prescribed methadone or electing non-pharmacological treatment

Published:2019-05-08 Issue:1 Volume:60 Page:1-11
ISSN:0363-0242
Container-title:Women & Health
language:en
Short-container-title:Women & Health

Author:

Jancaitis Brandi¹²,Kelpin Sydney³,Masho Saba¹⁴^ORCID,May James²³,Haug Nancy A.⁵,Svikis Dace³⁴

Affiliation:

1. Department of Family Medicine and Population Health, Division of Epidemiology, Virginia Commonwealth University, Richmond, VA, USA

2. Richmond Behavioral Health Authority, Richmond, VA, USA

3. Department of Psychology, Virginia Commonwealth University, Richmond, VA, USA

4. Institute for Women‘s Health, Virginia Commonwealth University, Richmond, VA, USA

5. Department of Psychology, Palo Alto University, Palo Alto, CA, USA

Funder

NIH/National Center on Minority Health and Health Disparities, Safer Sex Skill Building for Pregnant Drug Abusing Women

NIH/National Institute on Drug Abuse, Behavior Therapy Treatment Research Center

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03630242.2019.1610829

Reference40 articles.

1. Co‐occurring Psychiatric Symptoms Are Associated with Increased Psychological, Social, and Medical Impairment in Opioid Dependent Pregnant Women

2. Opioid dependence during pregnancy: relationships of anxiety and depression symptoms to treatment outcomes

3. Bishop, D., L. Borkowski, M. Couillard, A. Allina, S. Baruch, and S. Wood. 2017. Bridging the Divide White Paper: Pregnant Women and Substance Use: Overview of Research & Policy in the United States. Jacobs Institute of Women's Health.

4. The use of record linkage to examine illicit drug use in pregnancy

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Baseline Characteristics and Postdischarge Outcomes by Medication for Opioid Use Disorder Status Among Women with Polysubstance Use in Residential Treatment;Women's Health Reports;2023-12-01

2. A scoping review of opioid harm reduction interventions for equity-deserving populations;The Lancet Regional Health - Americas;2022-08

3. Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015–2018;Drug and Alcohol Dependence;2022-07

4. Eating attitudes, depressive symptoms, physical activity levels and menopausal symptoms of postmenopausal women diagnosed with coronavirus disease 2019 (COVID-19): a case-control study;Women & Health;2022-03-15

5. Disparities in opioid treatment access and retention among women based on pregnancy status from 2006 to 2017;Drug and Alcohol Dependence Reports;2022-03